Search results
Why Is AstraZeneca Stock Trading Lower On Tuesday?
Benzinga via Yahoo Finance· 3 days agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population in the...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 hours agoTruqap™ (capivasertib) plus fulvestrant now available in Canada Canada NewsWire MISSISSAUGA, ON, May 31, 2024 MISSISSAUGA, ON, May 31, 2024 /CNW/ - AstraZeneca is pleased ...
GP on the frontline of 100-day cough epidemic shares urgent warning
Daily Express· 3 days agoA doctor who worked on the frontline of a deadly epidemic has issued an urgent plea as cases of the...
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks· 3 days agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival data in a late-stage NSCLC study on Dato-DXd compared with docetaxel.
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3
FierceBiotech· 3 days agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga via Yahoo Finance· 2 days agoTuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first...
AstraZeneca’s (AZN) “Buy” Rating Reaffirmed at Citigroup
ETF DAILY NEWS· 3 days agoCitigroup reissued their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a report published on Tuesday, Marketbeat reports. Several other analysts have also ...
JPMorgan bullish on AstraZeneca stock, highlights AZD0780's sales By Investing.com
Investing.com· 3 days agoOn Tuesday, JPMorgan (NYSE:JPM) maintained its positive stance on AstraZeneca (NASDAQ:AZN:LN)...
Commerce Bank Trims Holdings in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 2 days agoCommerce Bank lessened its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 10.6% in the 4th quarter, according to the company in its most recent filing with the Securities ...
Health Care Roundup: Market Talk
The Wall Street Journal· 23 hours agoKeytruda is the world’s top-selling drug and raked in about $25 billion in revenue for Merck last year. (ben.glickman@wsj.com; @benglickman) 1151 ET – ...
